Medacta Group SA

    Jurisdiction
    Switzerland
    LEI
    506700P2PFU3A3DROC14
    ISIN
    CH0468525222 (MOVE.SW)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    trending_flat 51 / 100
    Even with peer group:
    51 / 100
    Fair value (Benjamin Graham formula)
    €120.11 33.4% overvalued
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €1.10B
    Gross margin
    67.9%
    EBIT
    €165.61M
    EBIT margin
    15.0%
    Net income
    €120.25M
    Net margin
    10.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €687.98M -37.5% €93.43M -22.3%
    €775.72M +12.8% €104.99M +12.4%
    €868.15M +11.9% €121.98M +16.2%

    Dividends

    Last dividend amount
    CHF 0.69
    Ex date
    Payment date
    Dividend payout ratio
    18.5%

    Earnings Calls

    Latest earnings call: September 8, 2025

    Add to watchlist

    Notifications